VEGF regulates cell behavior during vasculogenesis

被引:105
作者
Drake, CJ [1 ]
LaRue, A
Ferrara, N
Little, CD
机构
[1] Med Univ S Carolina, Dept Cell Biol, Charleston, SC 29425 USA
[2] Med Univ S Carolina, Cardiovasc Dev Biol Ctr, Charleston, SC 29425 USA
[3] Genentech Inc, San Francisco, CA 94080 USA
关键词
VEGF; vasculogenesis; angioblasts; morphogenesis;
D O I
10.1006/dbio.2000.9744
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Prominent among molecules that control neovascular processes is vascular endothelial growth factor (VEGF). The VEGF ligands comprise a family of well-studied mitogens/permeability factors that bind cell surface receptor tyrosine kinases. Targets include VEGF receptor-1/Flt1 and VEGF receptor-2/Flk1. Mice lacking genes for VEGF ligand or VEGF receptor-2 die early in gestation, making it difficult to determine the precise nature of underlying endothelial cellular behavior(s). To examine the effect(s) of VEGF signaling on cell behavior in detail, we conducted loss-of-function studies using avian embryos. Injection of soluble VEGFR-1 results in malformed vascular networks and the absence of large vessels. In the most severe cases embryos exhibited vascular atresia. Closely associated with the altered phenotype was a clear endothelial cell response-a marked decrease in cell protrusive activity. Further, we demonstrate that VEGF gain of function strikingly increased cell protrusive activity. Together, our data show that VEGF/VEGF receptor signaling regulates endothelial cell protrusive activity, a key determinant of blood vessel morphogenesis. We propose that VEGF functions as an instructive molecule during de novo blood vessel morphogenesis. (C) 2000 Academic Press.
引用
收藏
页码:178 / 188
页数:11
相关论文
共 32 条
[1]   SUPPRESSION OF RETINAL NEOVASCULARIZATION IN-VIVO BY INHIBITION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) USING SOLUBLE VEGF-RECEPTOR CHIMERIC PROTEINS [J].
AIELLO, LP ;
PIERCE, EA ;
FOLEY, ED ;
TAKAGI, H ;
CHEN, H ;
RIDDLE, L ;
FERRARA, N ;
KING, GL ;
SMITH, LEH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (23) :10457-10461
[2]   REQUIREMENT OF VASCULAR INTEGRIN ALPHA(V)BETA(3) FOR ANGIOGENESIS [J].
BROOKS, PC ;
CLARK, RAF ;
CHERESH, DA .
SCIENCE, 1994, 264 (5158) :569-571
[3]   ANGIOMORPHOLOGY OF THE HUMAN RENAL CLEAR CELL-CARCINOMA - A LIGHT AND SCANNING ELECTRON-MICROSCOPIC STUDY [J].
BUGAJSKI, A ;
NOWOGRODZKAZAGORSKA, M ;
LENKO, J ;
MIODONSKI, AJ .
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1989, 415 (02) :103-113
[4]   Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele [J].
Carmeliet, P ;
Ferreira, V ;
Breier, G ;
Pollefeyt, S ;
Kieckens, L ;
Gertsenstein, M ;
Fahrig, M ;
Vandenhoeck, A ;
Harpal, K ;
Eberhardt, C ;
Declercq, C ;
Pawling, J ;
Moons, L ;
Collen, D ;
Risau, W ;
Nagy, A .
NATURE, 1996, 380 (6573) :435-439
[5]  
COFFIN JD, 1988, DEVELOPMENT, V102, P735
[6]   TUMOR VASCULAR-PERMEABILITY FACTOR STIMULATES ENDOTHELIAL-CELL GROWTH AND ANGIOGENESIS [J].
CONNOLLY, DT ;
HEUVELMAN, DM ;
NELSON, R ;
OLANDER, JV ;
EPPLEY, BL ;
DELFINO, JJ ;
SIEGEL, NR ;
LEIMGRUBER, RM ;
FEDER, J .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (05) :1470-1478
[7]  
CRAKE CJ, 1997, DEV BIOL, V191, P1
[8]   THE FMS-LIKE TYROSINE KINASE, A RECEPTOR FOR VASCULAR ENDOTHELIAL GROWTH-FACTOR [J].
DEVRIES, C ;
ESCOBEDO, JA ;
UENO, H ;
HOUCK, K ;
FERRARA, N ;
WILLIAMS, LT .
SCIENCE, 1992, 255 (5047) :989-991
[9]  
Drake Christopher J., 1998, P3
[10]   VEGF and vascular fusion: Implications for normal and pathological vessels [J].
Drake, CJ ;
Little, CD .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1999, 47 (11) :1351-1355